Lung Diseases Clinical Trials in Kansas City, Kansas
7 recruitingKansas City, Kansas
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim400 enrolled158 locationsNCT06806592
Recruiting
Phase 3
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Interstitial Lung DiseasePulmonary HypertensionPulmonary Hypertension Due to Lung Diseases and Hypoxia
United Therapeutics900 enrolled62 locationsNCT06388421
Recruiting
Deep Functional Phenotyping of the ALA Lung Health Cohort
Lung Diseases
Johns Hopkins University1,000 enrolled12 locationsNCT06177717
Recruiting
American Lung Association (ALA) Lung Health Cohort
Lung Diseases
Johns Hopkins University4,000 enrolled37 locationsNCT04543461
Recruiting
Real World Registry for Use of the Ion Endoluminal System
Lung CancerLung NeoplasmsNeoplasms+6 more
Intuitive Surgical3,000 enrolled16 locationsNCT06004440
Recruiting
Pulmonary Hypertension Biorepository and Registry
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases and Hypoxia+6 more
University of Kansas Medical Center300 enrolled1 locationNCT04808596